Furthermore, patients with an elevated total score (TS) of HE4 between the two surgeries showed a trend towards a longer OS, compared to those with a non-elevated TS of HE4 [ Figure 2 C , the median OS (95% CI), 141.7 ± 17.6 (107.3-176.2) vs. 84.8 ± 5.1 (74.7-94.9) months, P = 0.076].
← all excerpts
HE4 and eIF3a Expression Correlates with Surgical Outcome and Overall Survival in Ovarian Cancer Patients with Secondary Cytoreduction.
1
—
—